{
  "retracted": false,
  "timestamp": 1581724800000,
  "updates": [
    {
      "timestamp": 1591719585909,
      "identifier": {
        "doi": "10.1016/j.bmcl.2019.126931"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.bmcl.2016.10.039"
  },
  "journal": "Bioorganic & Medicinal Chemistry Letters",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core” [Bioorg. Med. Chem. Lett. 26 (2016) 5399–5402]"
}
